The near-certain trader consensus against a hantavirus pandemic in 2026 stems from the successful containment of the sole notable 2026 cluster—an Andes virus outbreak on the MV Hondius cruise ship that produced roughly 13 cases and three deaths in April, followed by no sustained person-to-person transmission beyond the vessel despite international contact tracing across multiple countries. Official CDC, HHS, and South American health ministry data through late August confirm all U.S. monitoring ended in June with zero domestic cases, while Argentina’s 102 seasonal cases and Chile’s elevated but regionally concentrated rural reports reflect typical rodent-borne endemic patterns rather than exponential global spread. Hantavirus pulmonary syndrome remains primarily zoonotic via rodent excreta, with the Andes strain’s limited human-to-human capability proving insufficient for pandemic thresholds under current surveillance. Any shift would require unforeseen mutation or massive rodent surges, neither of which official monitoring indicates as of August 2026.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedHantavirus pandemic in 2026?
Hantavirus pandemic in 2026?
4% chance
$17,943,357 Vol.
$17,943,357 Vol.
Dec 30, 2026
4% chance
$17,943,357 Vol.
$17,943,357 Vol.
Dec 30, 2026
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.The near-certain trader consensus against a hantavirus pandemic in 2026 stems from the successful containment of the sole notable 2026 cluster—an Andes virus outbreak on the MV Hondius cruise ship that produced roughly 13 cases and three deaths in April, followed by no sustained person-to-person transmission beyond the vessel despite international contact tracing across multiple countries. Official CDC, HHS, and South American health ministry data through late August confirm all U.S. monitoring ended in June with zero domestic cases, while Argentina’s 102 seasonal cases and Chile’s elevated but regionally concentrated rural reports reflect typical rodent-borne endemic patterns rather than exponential global spread. Hantavirus pulmonary syndrome remains primarily zoonotic via rodent excreta, with the Andes strain’s limited human-to-human capability proving insufficient for pandemic thresholds under current surveillance. Any shift would require unforeseen mutation or massive rodent surges, neither of which official monitoring indicates as of August 2026.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Market Opened: May 4, 2026, 10:26 AM ET
Volume
$17,943,357End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.The near-certain trader consensus against a hantavirus pandemic in 2026 stems from the successful containment of the sole notable 2026 cluster—an Andes virus outbreak on the MV Hondius cruise ship that produced roughly 13 cases and three deaths in April, followed by no sustained person-to-person transmission beyond the vessel despite international contact tracing across multiple countries. Official CDC, HHS, and South American health ministry data through late August confirm all U.S. monitoring ended in June with zero domestic cases, while Argentina’s 102 seasonal cases and Chile’s elevated but regionally concentrated rural reports reflect typical rodent-borne endemic patterns rather than exponential global spread. Hantavirus pulmonary syndrome remains primarily zoonotic via rodent excreta, with the Andes strain’s limited human-to-human capability proving insufficient for pandemic thresholds under current surveillance. Any shift would require unforeseen mutation or massive rodent surges, neither of which official monitoring indicates as of August 2026.
This market will resolve to "Yes" if the World Health Organization explicitly characterizes Hantavirus, Hantavirus Pulmonary Syndrome (HPS), Hemorrhagic Fever with Renal Syndrome (HFRS), or a Hantavirus-related outbreak as a "pandemic" in an official public communication between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Volume
$17,943,357End Date
Dec 31, 2026Market Opened
May 4, 2026, 10:26 AM ETResolver
0x65070BE91...The near-certain trader consensus against a hantavirus pandemic in 2026 stems from the successful containment of the sole notable 2026 cluster—an Andes virus outbreak on the MV Hondius cruise ship that produced roughly 13 cases and three deaths in April, followed by no sustained person-to-person transmission beyond the vessel despite international contact tracing across multiple countries. Official CDC, HHS, and South American health ministry data through late August confirm all U.S. monitoring ended in June with zero domestic cases, while Argentina’s 102 seasonal cases and Chile’s elevated but regionally concentrated rural reports reflect typical rodent-borne endemic patterns rather than exponential global spread. Hantavirus pulmonary syndrome remains primarily zoonotic via rodent excreta, with the Andes strain’s limited human-to-human capability proving insufficient for pandemic thresholds under current surveillance. Any shift would require unforeseen mutation or massive rodent surges, neither of which official monitoring indicates as of August 2026.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions